Boston, MA 06/04/2013 (wallstreetpr) – The share prices of MannKind Corporation (NASDAQ:MNKD) had surged by 14.56 percent to close at $7.63 per share for the end of last trading session on Monday. The shares of the company had been trading in the range of $6.83 to $7.67 per share during the day. The shares of MannKind Corporation (NASDAQ:MNKD) had thereby hit new 52 week high price level at $7.67 per share owing to the surge in prices and 52 week low price level of the shares is at $1.65 per share.
MannKind Corporation (NASDAQ:MNKD) is basically involved in the development, commercialization and distribution of treatment therapies for diseases like diabetics and cancer. The development stage bio pharmaceutical company would be presenting at the Jefferies Global Health Care Conference, 2013 being held at New York City between June 03 and June 06, 2013.
The presentation to be made by MannKind Corporation (NASDAQ:MNKD) at the conference is surrounded by expectations which is causing the recent surge in share prices and trading volumes of the company. The Jefferies Global Health Care Conference would witness large number of participating companies in wide range of pharmaceutical, bio technology and such other related sectors. The participants and attendees would thereby be provided with valuable information to take away from the conference.
The average trading volume of MannKind Corporation (NASDAQ:MNKD) is at 6.91 million shares per day which had been surging to higher volumes in the recent days. The company presently has 290.88 million shares outstanding in the market.